A nurse is caring for a patient who suddenly develops signs of anaphylaxis after receiving an intravenous antibiotic. The patient exhibits severe respiratory distress, hypotension, and urticaria. What is the nurse's highest priority action?

Epinephrine is the first-line treatment for anaphylaxis and must be administered immediately to counteract life-threatening symptoms like respiratory distress and hypotension. Other interventions (oxygen, IV access, positioning) are supportive but secondary.

Understanding the Priority: Why Epinephrine Comes First

In the management of anaphylaxis, the sequence of interventions is critical. Anaphylaxis is defined as a severe, potentially fatal systemic hypersensitivity reaction characterized by sudden multi-system involvement and rapid hemodynamic compromise ^[1]. The patient's presentation—severe respiratory distress, hypotension, and urticaria—indicates a life-threatening cascade of mediator release from mast cells and basophils. While all the listed options are components of comprehensive anaphylaxis management, the highest priority is to halt this cascade at its source.

Pharmacological Rationale for Epinephrine

Administering epinephrine 0.3-0.5 mg intramuscularly (IM) into the anterolateral thigh is the first-line, life-saving intervention. The rationale is based on its unique, non-substitutable pharmacological properties that directly counteract the pathophysiological mechanisms of anaphylaxis:
- Alpha-1 adrenergic agonism: Causes potent vasoconstriction, which directly reverses peripheral vasodilation, reduces mucosal edema (including laryngeal edema), and elevates blood pressure, addressing the patient's hypotension.
- Beta-1 adrenergic agonism: Increases myocardial contractility and heart rate, providing direct cardiac support.
- Beta-2 adrenergic agonism: Induces bronchodilation, relieving the severe respiratory distress. Crucially, it also stabilizes mast cells and basophils, suppressing the further release of histamine, leukotrienes, and other inflammatory mediators that drive the reaction.

The evidence is unequivocal that delayed epinephrine administration is a primary driver of preventable deaths in anaphylaxis ^[1]. No other medication, including antihistamines or corticosteroids, can achieve this combination of life-sustaining effects with the necessary speed.

Analysis of Other Options

- Option 1 (Administer high-flow oxygen): Oxygenation is a vital supportive measure for hypoxemia. However, in the context of profound bronchoconstriction and airway edema, simply applying oxygen does not address the underlying obstruction. The airway must first be opened with epinephrine's bronchodilatory and anti-edema effects for oxygenation to be effective. It is a secondary, not primary, action.
- Option 2 (Establish a second large-bore IV access): Fluid resuscitation with isotonic crystalloids is essential for managing the distributive shock of anaphylaxis, as massive vasodilation and increased vascular permeability cause significant intravascular volume depletion. Establishing IV access is a high-priority nursing action, but it follows the immediate administration of IM epinephrine. The IM route for epinephrine is recommended first-line because it achieves peak plasma concentrations faster and more reliably than the delay inherent in preparing and starting an IV line in a crashing patient .
- Option 4 (Position the patient in Trendelenburg position): The Trendelenburg position is not recommended in anaphylaxis. The correct positioning is supine with the lower extremities elevated to promote venous return, unless this compromises the airway or breathing. If respiratory distress is severe, the patient may be allowed to sit upright to facilitate breathing, but they should not stand or be moved abruptly due to the risk of sudden cardiac collapse from empty ventricle syndrome. This is a supportive measure, not the priority intervention.

Clinical Application of the Evidence

The management of anaphylaxis is time-critical, and the nursing priority reflects the most immediate threat to life. The multi-system involvement described in the literature—sudden onset with respiratory and cardiovascular compromise—demands a rapid and decisive response [1,2]. The pragmatic approach, reinforced by recent pediatric and adult guidelines, emphasizes that IM epinephrine is the cornerstone of initial management and should be administered as soon as anaphylaxis is recognized . Delaying its administration to perform other interventions, such as establishing IV access or applying oxygen, is a common and dangerous error that increases the risk of poor outcomes ^[1]. Therefore, the nurse's highest priority action is to immediately halt the progression of the reaction by administering IM epinephrine.